Clinical Trials Logo

Clinical Trial Summary

To evaluate the effect of atorvastatin 80 mg, versus placebo, given for 12 months on carotid intima-media thickness in postmenopausal women with moderate hypercholesterolemia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00163163
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 3
Start date January 2003
Completion date July 2006

See also
  Status Clinical Trial Phase
Completed NCT01935674 - Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels Phase 4
Completed NCT02890992 - An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Phase 2
Completed NCT00653835 - Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435) Phase 4
Recruiting NCT06008756 - MK-0616 (Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes Phase 3
Completed NCT02585778 - Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin) Phase 3
Completed NCT00329173 - PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin. Phase 3
Completed NCT04169386 - A Study of PCSK9 Inhibitor AK102 in Healthy Subjects Phase 1
Completed NCT02770131 - Chart Review of Repatha® in Subjects With Hyperlipidaemia
Completed NCT03510884 - An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Phase 3
Recruiting NCT06275724 - Specified Drug-use Survey of Leqvio for s.c. Injection.
Completed NCT03415178 - Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy Phase 3
Completed NCT01779687 - Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin. Phase 1
Completed NCT01617655 - Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH) Phase 3
Completed NCT00328523 - TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) Phase 3
Completed NCT05934292 - MK-0616 (Oral PCSK9 Inhibitor) Renal Impairment Study 2 (MK-0616-020) Phase 1
Completed NCT01257971 - Non-interventional Study (NIS) to Assess Reaching of Cholesterol Target Values in Patients Treated With HMG-CoA Reductase Inhibitors N/A
Completed NCT01597700 - Acotral® Versus Zetia® Ezetimibe Bioequivalance Study. Phase 1
Terminated NCT02906124 - Study to Evaluate the Safety of Repatha® in Pregnancy
Completed NCT01711749 - Rosuvastatin Calcium Bioequivalence Study - Fast Phase 1
Completed NCT02065180 - The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome Phase 4